ABCL
$11.37-7.11%
ABCL financial statements
The full income statement, balance sheet, and cash-flow statement for AbCellera Biologics Inc. (ABCL), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 294.7M2024-09 295.4M2024-12 298.0M2025-03 298.5M2025-06 298.8M2025-09 299.3M2025-12 303.2M2026-03 305.4M2026-06 306.6M+4.1% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 75.1M+160.6% | 28.8M-24.2% | 38.0M-92.2% | 485M+29.4% | 375M+60.9% | |
| 292M-14.9% | 344M+24.8% | 275M+2.3% | 269M+57.5% | 171M+121.4% | ||
| Research & development | 187M+11.7% | 167M-4.8% | 176M+62.8% | 108M+73.8% | 62.1M+111.1% | |
| Selling, general & administrative | 83.2M-2.6% | 85.5M+13.7% | 75.2M+35.5% | 55.5M+32.6% | 41.8M+251.4% | |
| General & administrative | 83.2M-2.6% | 85.5M+13.7% | 75.2M+35.5% | 55.5M+32.6% | 41.8M+251.4% | |
| Selling & marketing | — | 12.8M-9.9% | 14.2M+25.8% | 11.3M+63.0% | 6.91M+79.9% | |
| Amortization of intangibles | 3.70M-74.1% | 14.3M+23.3% | 11.6M+10.5% | 10.5M+4.0% | 10.1M+304.0% | |
| Operating income | -217M+31.0% | -315M-32.7% | -237M-209.6% | 217M+5.9% | 204M+31.0% | |
| Interest & investment income | 28.3M-26.4% | 38.5M-8.9% | 42.2M+162.7% | 16.1M+382.9% | 3.33M+1036.5% | |
| Other non-operating income | -2.71M-104.4% | 62.3M+819.1% | 6.78M+267.5% | -4.04M+33.5% | -6.08M+10.7% | |
| Equity-method income | — | 1.70M-5.6% | 1.80M+100.0% | 900K | 0.00 | |
| Gain (loss) on equity securities | 800K+0.0% | 800K-61.9% | 2.10M+223.5% | -1.70M-440.0% | 500K | |
| Pre-tax income | -178M+11.4% | -200M-15.2% | -174M-172.8% | 239M+9.1% | 219M+38.8% | |
| Income tax | -31.2M+16.9% | -37.5M-35.9% | -27.6M-134.3% | 80.6M+22.7% | 65.7M+68.8% | |
| -146M+10.1% | -163M-11.2% | -146M-192.4% | 159M+3.3% | 153M+29.1% | ||
| Net income to common | -146M+10.1% | -163M-11.2% | -146M-192.4% | 159M+3.3% | 153M+80.3% | |
| -$0.49+10.9% | -$0.55-7.8% | -$0.51-202.0% | $0.50+4.2% | $0.48+6.7% | ||
| EPS (basic) | -$0.49+10.9% | -$0.55-7.8% | -$0.51-191.1% | $0.56+0.0% | $0.56+5.7% | |
| Weighted-avg shares (basic) | 299M+1.5% | 294M+1.8% | 289M+1.4% | 285M+3.4% | 276M+73.2% | |
| Weighted-avg shares (diluted) | 299M+1.5% | 294M+1.8% | 289M-8.2% | 315M-1.1% | 318M+21.0% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 728M-3.1% | 751M-13.8% | 872M-15.0% | 1.03B+10.3% | 930M+14.3% | ||
| Cash & equivalents | 129M-17.8% | 156M+17.3% | 133M-65.5% | 387M-18.8% | 476M-19.9% | |
| Cash & short-term investments | 534M-14.7% | 626M-17.7% | 761M | — | — | |
| Accounts receivable | 39.4M+23.2% | 32.0M | 0.00 | — | — | |
| Inventory | 6.34M | 0.00 | — | — | — | |
| Other current assets | 111M+65.5% | 67.1M+20.3% | 55.8M-26.0% | 75.4M+254.9% | 21.2M+255.9% | |
| 1.36B-0.3% | 1.36B-8.6% | 1.49B-3.4% | 1.54B+16.9% | 1.32B+31.1% | ||
| Property, plant & equipment | — | — | — | 217M+94.6% | 112M+522.8% | |
| Operating lease right-of-use | 136M+104.2% | 66.6M-8.9% | 73.1M-9.5% | 80.8M | — | |
| Goodwill | 47.8M+0.0% | 47.8M+0.0% | 47.8M+0.0% | 47.8M+0.0% | 47.8M+51.8% | |
| Intangible assets | 38.4M-8.9% | 42.1M-65.0% | 120M-8.4% | 132M-11.4% | 148M+28.9% | |
| Other non-current assets | 51.9M-46.2% | 96.5M+2.4% | 94.2M+103.4% | 46.3M+51.2% | 30.6M+265.3% | |
| Total non-current assets | 629M+3.2% | 609M-1.1% | 616M+19.5% | 515M+32.6% | 389M+102.3% | |
| 64.3M-16.1% | 76.6M-35.6% | 119M+0.6% | 118M-2.0% | 121M+16.6% | ||
| Accrued liabilities | 25.2M-26.6% | 34.4M+20.1% | 28.6M | 0.00 | 0.00-100.0% | |
| Deferred revenue | 13.5M+0.0% | 13.5M-28.7% | 19.0M-12.3% | 21.6M+186.8% | 7.54M+14.4% | |
| Current lease liability | 5.82M+25.8% | 4.62M-25.0% | 6.16M+10.3% | 5.58M+52.9% | 3.65M+441.0% | |
| 390M+28.1% | 304M-9.3% | 336M+9.1% | 308M+5.1% | 293M+67.3% | ||
| Deferred revenue (non-current) | 3.50M-38.6% | 5.70M-30.4% | 8.20M-58.0% | 19.5M-28.8% | 27.4M | |
| Non-current lease liability | 137M+126.2% | 60.7M-14.7% | 71.2M-7.1% | 76.7M+110.6% | 36.4M+880.2% | |
| Operating lease liability (total) | 143M+119.1% | 65.4M-15.5% | 77.4M-5.9% | 82.3M+105.3% | 40.1M+812.6% | |
| Deferred tax liabilities | 9.12M-9.3% | 10.1M-67.2% | 30.6M-7.7% | 33.2M-11.2% | 37.4M+42.8% | |
| Other non-current liabilities | 10.4M+44.8% | 7.17M+21.4% | 5.91M+91.4% | 3.09M+78.1% | 1.73M-73.8% | |
| Total non-current liabilities | 326M+43.0% | 228M+5.1% | 217M+14.5% | 189M+10.0% | 172M+140.7% | |
| 967M-8.4% | 1.06B-8.4% | 1.15B-6.6% | 1.23B+20.2% | 1.03B+23.5% | ||
| Common stock | 802M+3.2% | 777M+3.2% | 753M+2.6% | 734M+1.7% | 722M+1.7% | |
| Additional paid-in capital | 198M+19.2% | 166M+37.4% | 121M+63.3% | 74.1M+109.6% | 35.4M+497.3% | |
| Retained earnings | -29.5M-125.2% | 117M-58.2% | 280M-34.4% | 426M+59.2% | 268M+134.4% | |
| Accumulated other comprehensive income | -4.23M+3.3% | -4.38M-154.5% | -1.72M-23.7% | -1.39M-596.8% | 280K | |
| Total liabilities & equity | 1.36B-0.3% | 1.36B-8.6% | 1.49B-3.4% | 1.54B+16.9% | 1.32B+31.1% | |
| Common shares issued | 301M+1.6% | 296M+1.7% | 291M+1.4% | 287M+1.3% | 283M+5.1% | |
| Common shares outstanding | 301M+1.6% | 296M+1.7% | 291M+1.4% | 287M+1.3% | 283M+5.1% | |
| Shares outstanding (cover) | 303M+1.7% | 298M+1.8% | 293M+1.8% | 288M+1.3% | 284M | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -131M-20.9% | -109M-147.4% | -43.9M-115.8% | 277M+13.4% | 245M+977.9% | ||
| Depreciation & amortization | 22.1M-17.5% | 26.8M+10.0% | 24.4M-12.4% | 27.8M+92.7% | 14.5M+198.8% | |
| Intangible amortization | 3.70M-74.1% | 14.3M+23.3% | 11.6M+10.5% | 10.5M+4.0% | 10.1M+304.0% | |
| Share-based compensation | 55.8M-17.4% | 67.6M+5.3% | 64.2M+29.7% | 49.5M+61.5% | 30.6M+265.0% | |
| Deferred income taxes | — | — | 1.96M+192.7% | -2.11M-4.8% | -2.02M-196.2% | |
| 87.8M-27.7% | 121M+154.9% | -221M+37.3% | -353M-6.1% | -332M-177.4% | ||
| Capital expenditure | 42.8M-45.4% | 78.4M+1.9% | 76.9M+8.9% | 70.7M+20.9% | 58.5M+504.3% | |
| Free cash flow | -174M+6.9% | -187M-54.7% | -121M-158.5% | 207M+11.1% | 186M+1329.9% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 11.5M-86.9% | |
| 14.1M+10.3% | 12.8M+23.3% | 10.4M+736.1% | -1.63M+58.1% | -3.89M-100.6% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 872K-94.4% | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 1.82M-90.9% | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | 1.10M+141.9% | -2.62M-544.3% | 589K+106.1% | -9.60M-573.6% | -1.43M | |
| Net change in cash | -28.4M-223.3% | 23.0M+109.1% | -254M-193.7% | -86.5M+7.0% | -93.0M-115.9% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 1.04B+18.7% | 873M-47.3% | 1.66B-42.8% | 2.90B-28.6% | 4.06B-62.6% | |
| P/E | — | — | — | 11.7×-55.9% | 26.5×-71.0% | |
| P/S | 13.8×-54.4% | 30.3×-7.9% | 32.9×+584.3% | 4.8×-55.6% | 10.8×-76.7% | |
| P/B | 1.1×+29.7% | 0.8×-41.0% | 1.4×-39.6% | 2.3×-41.4% | 4.0×-69.7% | |
| P/FCF | — | — | — | 17.9×-18.0% | 21.8×-97.4% | |
| Earnings yield | — | — | — | 8.6%+126.7% | 3.8%+244.7% | |
| FCF yield | — | — | — | 5.6%+21.9% | 4.6%+3719.3% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: ABCL’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ABCL filings on SEC EDGAR → Not investment advice.